The goal of this prospective study is to gain insight into the endophenotypic variation in OSA, with a focus on the underlying pathophysiological traits and the cardiovascular alterations associated with the condition. To capture the variability in OSA endophenotypes, novel metrics that extend beyond the AHI will be considered, with particular attention to the sleep-apnea-specific hypoxic burden, the sleep-apnea-specific heart rate response, and pulse wave amplitude drops (PWADs). Since the impact of treatment on cardiovascular parameters remains an important point of interest, the effects of different treatment modalities on cardiovascular changes will be investigated, including continuous positive airway pressure (CPAP), mandibular advancement devices (MADs), and hypoglossal nerve stimulation.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Sleep apnea-specific hypoxic burden (SASHB)
Timeframe: 1 year
Cardiovascular outcome: interventricular septum thickness
Timeframe: 1 year
Cardiovascular outcome: left ventricular ejection fraction
Timeframe: 1 year
Cardiovascular outcome: heart rate variability
Timeframe: 1 year
OSA efficacy: delta apnea-hypopnea index (AHI)
Timeframe: 1 year